Wolverine Trading’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-205
Closed -$21K 5100
2023
Q1
$21K Buy
205
+51
+33% +$4.38K ﹤0.01% 4003
2022
Q4
$8K Buy
+154
New +$8.52K ﹤0.01% 3828
2022
Q3
Sell
-251
Closed -$13K 5506
2022
Q2
$13K Sell
251
-95
-27% -$5.7K ﹤0.01% 4296
2022
Q1
$20K Sell
346
-29
-8% -$1.76K ﹤0.01% 5249
2021
Q4
$25K Sell
375
-14
-4% -$1.22K ﹤0.01% 5478
2021
Q3
$39K Sell
389
-303
-44% -$32.4K ﹤0.01% 6059
2021
Q2
$79K Buy
+692
New +$80.3K ﹤0.01% 5501
2021
Q1
Sell
-388
Closed -$40K 6512
2020
Q4
$40K Buy
+388
New +$45.8K ﹤0.01% 4643

Other funds holding QNTM

Wolverine Trading's QNTM Position: Q4 2022 in Review

Wolverine Trading sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q4 2022, closing a stake of 184 shares — an estimated $10.2K sold.

Wolverine Trading first reported a position in QNTM in Q3 2021 and held it in 4 quarters. The position peaked at $20K in Q4 2021. 14 funds tracked by Wall St. Rank hold QNTM as of Q4 2022.

  • Wolverine Trading reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 184 Quantum Biopharma Class B Subordinate Voting Shares shares in Q4 2022, an estimated $10.2K.
  • Wolverine Trading first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2021 and held it in 4 quarters.
  • Wolverine Trading's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $20K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.